| Financial Year |
March 31 2023 |
| Monetary Funds |
2,190,370,935.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,837,575.28 |
| Accounts Receivable |
74,700,954.46 |
| Advances to Suppliers |
376,208,420.18 |
| Other Receivables |
33,674,402.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
674,349,208.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,250,000.00 |
| Other Current Assets |
163,144,642.52 |
| Total Current Assets |
4,664,436,707.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
92,730,625.46 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
4,655,777,120.30 |
| Under-construction Projects |
279,848,418.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
154,065,018.65 |
| R&D expenses |
-- |
| Goodwill |
859,840,538.26 |
| Long-Term Deferred and Prepaid Expenses |
5,048,867.62 |
| Deferred Income Tax Assets |
277,221,152.16 |
| Other Non-Current Assets |
656,213,762.87 |
| Sub-Total of Non-Current Assets |
6,985,155,018.28 |
| Total Assets |
11,649,591,725.65 |
| Short-Term Loans |
449,845,148.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,068,653,596.30 |
| Accounts Payable |
1,095,759,934.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,072,654.13 |
| Taxes Payable |
17,785,214.68 |
| Interest Payable |
-- |
| Dividend Payable |
89,600.00 |
| Other payables |
1,048,764,203.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
662,043,458.48 |
| Other Current Liabilities |
54,395,763.17 |
| Sub-Total of Current Liabilities |
4,881,240,693.88 |
| Long-term Loans |
2,157,240,767.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,681,725,477.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
350,754,126.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,333,581,785.44 |
| Total Liabilities |
10,214,822,479.32 |
| Paid-In Capital(Or Share Stock) |
142,181,673.00 |
| Capital Surplus |
125,620,297.24 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,166,967,276.09 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,434,769,246.33 |
| Owner's Equity（Stockholder's Equity） |
1,434,769,246.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,649,591,725.65 |
